Bone Biologics Corp
BBLGW- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $400.1K in total; no superinvestor holds it.
Other share classesBBLG
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 2
- 13F valueReported value at the end of Q2 2026
- $400.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BBLGW, Q2 2026
No superinvestor reported holding BBLGW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bone Biologics Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +8.00K | $0.64 | +$5.12K | +114.3%15.0K after | |
| Sep 12, 2023 (view filing) | Sep 11 | 1 day | Frelick JeffChief Executive Officer | PPurchase | +9.50K | $0.69 | +$6.55K | +123.3%17.2K after | |
| Sep 7, 2023 (view filing) | Sep 6 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +7.00K | $0.7096 | +$4.97K | New position7.00K after | 2 lots |
| Sep 5, 2023 (view filing) | Aug 31 | 5 days | Frelick JeffChief Executive Officer | PPurchase | +7.60K | $0.66 | +$5.02K | +7,307.7%7.70K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bone Biologics Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 26,398 | $396.0K | 0.00% | −3,354−11.3% | Reduced |
| UBS Group AG | 513 | $4.10K | 0.00% | +91+21.6% | Added |